Abstract 4733: Efficacy and Safety of Magnetic Resonance Imaging versus Computed Tomography-Guided Reperfusion in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Wirksamkeit und Sicherheit von Magnetresonanztomografie versus computertomografisch gesteuerter Reperfusion beim akuten ischämischen Schlaganfall: systematische Übersicht und Metaanalyse
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.4733 ↗Auf einen Blick
Die Metaanalyse fand bei Erwachsenen mit akutem ischämischem Schlaganfall unter MRI-gestützter Reperfusion bessere funktionelle Ergebnisse, geringere Mortalität und weniger sICH als unter CT-gestützter Reperfusion.
Fragestellung
Unterscheidet sich die MRI-gestützte im Vergleich zur CT-gestützten Reperfusion bei Erwachsenen mit akutem ischämischem Schlaganfall hinsichtlich Mortalität, Funktion und Sicherheit?
Methode
Systematische Übersicht und Metaanalyse nach PRISMA; Suche in PubMed, Embase, Cochrane Library, Web of Science, CINAHL und Google Scholar bis Oktober 2025; RCTs, QRCTs sowie Kohorten- und Fall-Kontroll-Studien.
Ergebnisse
13 Studien mit n = 27.313; Metaanalyse von 11 Studien (n = 27.197). MRI-R: mRS 0–2 nach 90 Tagen RR 1,28 (95 %-KI 1,06–1,55), Mortalität RR 0,72 (95 %-KI 0,62–0,84), sICH RR 0,59 (95 %-KI 0,45–0,78).
Einschränkungen
Studien unterschieden sich in Design, Setting und Reperfusionsverfahren; Heterogenität bei der funktionellen Unabhängigkeit hoch (I 2 = 82,6 %).
Schlussfolgerung der Autor:innen
MRI-R war mit besseren funktionellen Ergebnissen, niedrigerer Mortalität und weniger sICH verbunden als CT-gestützte Ansätze. Weitere prospektive multizentrische Studien seien nötig.
Kernaussagen
- MRI-R: mRS 0–2 nach 90 Tagen RR 1,28 (95 %-KI 1,06–1,55)
- Mortalität RR 0,72 (95 %-KI 0,62–0,84)
- sICH RR 0,59 (95 %-KI 0,45–0,78)
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Sabia Afreen und 10 weiteren Autor:innen.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
Acute ischemic stroke (AIS), which accounts for the majority of stroke cases, remains a leading cause of death and disability worldwide. Timely reperfusion improves outcomes, but optimal patient selection depends heavily on neuroimaging. Computed Tomography (CT) is widely used for its speed and accessibility, whereas Magnetic Resonance Imaging (MRI) offers greater precision in identifying salvageable tissue, prompting ongoing debate over its role in acute stroke care. Research Question/Hypothesis This systematic review (SR) and meta-analysis (MA) compared MRI-guided reperfusion (MRI-R) versus CT-guided reperfusion (CT-R) strategies in adult AIS to evaluate differences in mortality, functional and safety outcomes.
Methods
In accordance with PRISMA guidelines (PROSPERO: CRD420251165578), we conducted a SR and searched PubMed, Embase, Cochrane Library, Web of Science, CINAHL, and Google Scholar from inception to October 2025 for English and Spanish studies comparing MRI-R versus CT-R in adults with AIS. Randomized trials (RCTs), quasi-randomized controlled trials (QRCTs), cohort and case-control designs were included. Primary outcome was mortality; secondary outcomes were 90-day functional independence (modified Rankin Scale [mRS] 0-2) and symptomatic intracranial hemorrhage (sICH). MA was performed using R software with a random-effects model. Risk of bias was evaluated using Cochrane RoB 2.0 and ROBINS tools.
Results
Of 11,578 records identified, 8,562 were screened after duplicate removal, and 13 studies (n = 27,313) met the inclusion criteria. MRI-guided strategies was used in all intervention arms, with CT-R used as comparators. Studies spanned eight countries and varied in design (cohort, RCT, QRCT), setting (single-center vs multicenter), and reperfusion modality (thrombolysis, thrombectomy, or both). MA of 11 studies (n = 27,197) showed that MRI-R was associated with improved functional independence at 90 days (mRS 0 to 2: risk ratio [RR] = 1.28, 95% confidence interval [CI]: 1.06 to 1.55; p = 0.01; I 2 = 82.6%), alongside reduced mortality (RR = 0.72, 95% CI: 0.62 to 0.84; p = 0.002; I 2 = 0.0%) and lower rates of sICH (RR = 0.59, 95% CI: 0.45 to 0.78; p = 0.002; I 2 = 7.6%).
Conclusion
MRI-R yields improved functional outcomes, reduced mortality, and lower sICH rates compared to CT-guided approaches. CT-R remains widely used due to its speed and broad availability, allowing rapid therapy initiation. However, with improving workflows, MRI-R may support a more individualized, tissue-based approach in AIS management. Further prospective, multicenter studies are needed to validate these observations and integrate MRI-R into contemporary stroke care pathways.
Zitieren
APA
Afreen, S., Sánchez, M. S., Villa, M., Bajana, A. M., Kumar, A., Diaz, R., Sotelo, R. A., Montecinos, B. G. D., Abad, E., Moreno, S. C. S., & Martinez, E. C. (2026). Abstract 4733: Efficacy and Safety of Magnetic Resonance Imaging versus Computed Tomography-Guided Reperfusion in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.4733
Vancouver
Afreen S, Sánchez MS, Villa M, Bajana AM, Kumar A, Diaz R, et al. Abstract 4733: Efficacy and Safety of Magnetic Resonance Imaging versus Computed Tomography-Guided Reperfusion in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.4733
BibTeX
@article{Afreen2026,
author = {Afreen, Sabia and Sánchez, Michelle Sámano and Villa, Montserrat and Bajana, Angelo Magallanes and Kumar, Ajay and Diaz, Ruth and Sotelo, Ricardo Asdrubal and Montecinos, Beatriz Gonzalez de and Abad, Edelvira and Moreno, Stephani Carolina Salvatierra and Martinez, Ernesto Calderon},
title = {Abstract 4733: Efficacy and Safety of Magnetic Resonance Imaging versus Computed Tomography-Guided Reperfusion in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.4733}
}
EUVIMED